UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

 

(Addresses of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

 

Form 20-F Form 40-F Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 14, 2025 its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 shares of the Company's Class A Ordinary Shares at a price of $13.29 per share in the open market for a total purchase price of $398,821, bringing his total holdings to 75,553 Class A Ordinary Shares.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.